MarkWide Research

Sale!

Diagnostic Biomarkers Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: August, 2022
No of Pages: 172
Delivery Format: PDF + Excel

$2,950.00

The global Diagnostic Biomarkers market was valued at USD 45.9 Billion in 2021. It is expected to reach USD 95.1 Billion in 2028, at a CAGR of 12.1% over the forecast period 2022-2028. Biomarkers can be defined as biological processes or chemicals found in bodily fluids like blood. They are then measured in the affected areas. They can indicate healthy or unhealthy bodily functions. Biomarkers can be used for many purposes, including diagnosis of Disease, prediction, treatment response evaluation, and prognosis. Diagnostic biomarkers detect Patent Ductus Arteriosus early in its development (PDA). Predictive markers are used to personalize treatment plans. Prognostic markers can predict survival rates and recurrence patterns. A variety of disorders can be detected using biomarkers in clinical diagnostics. To diagnose renal insufficiency, amylase can diagnose pancreatitis, while troponin levels can be used to diagnose myocardial injury.

Biomarkers can be used to apply clinical trials and analytical epidemiology to understand the dynamics of neurological diseases. Diagnostic biomarkers are useful in expanding our knowledge of the Disease’s underlying pathology and allowing us to classify disease-related risk factors. Biomarkers can be used to provide vital information from the beginning through the end about a disease. A perfect diagnosis requires careful evaluation of biomarkers’ validity concerning each stage. The causes can vary from one person to another and from laboratory to laboratory.

Technology Advancement

The growth in diagnostic biomarker revenues is expected to increase based on the prevalence of diseases such as cancer and other cardiac problems. The market for diagnostic biomarkers will see significant molecular biology growth and laboratory procedure advancements over the forecast period.

Biomarkers have become easier to diagnose many diseases, including cancers, genetic, heart, and other immunological disorders. Clinical investigators can use biomarkers to help them understand the full spectrum of neurological diseases.

Shortage in Cancer Vaccines

A variety of factors will limit market expansion. Market expansion may be hindered by the inability to provide cancer vaccines for distant areas and the need for special storage and transportation. However, promising growth prospects are possible due to the increasing public awareness of cancer diseases, higher government and private sector investments, and untapped potential within emerging economies.

Diagnostic Biomarkers market scope:

ParameterMore Details
For Years, Market Size2016-2030
Base Year2021
Historic Years2016-2021
Prediction Years2022-2030
Segments covered
  • Maladies
    • Cancer
    • Cardiovascular Diseases
    • Neurological Diseases
    • Immunological Diseases
    • Other
  • Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
Companies Covered
  • Biocrates Life Sciences AG
  • Augurex Life Sciences Corp.
  • Biomedical Corporation.
  • Target Discovery
  • Banyan Biomarkers Inc.
  • Astute Medical Inc.
  • Axela Inc.
  • Others

Report coverage Market growth drivers, limitations, and opportunities. Porter’s five force analysis, PEST analysis and value chain analysis. Patent analysis. Technology landscape analysis. Company market share analysis. COVID-19 impact analysis.

Market Segmentation :

BY TYPES

  • Biomarker of Exposure
  • Biomarker of Diseases

BY APPLICATIONS

  • Risk Assessment
  • Development of Molecular Diagnostic
  • Disease Diagnosis
  • Drug Discovery and Development
  • Drug Formulation
  • Forensic Application
  • Others (DNA Fingerprinting and Others)

BY SERVICES

  • Sample Preparation
  • Assay Development
  • Biomarker Validation and Testing
  • Other Services

North America Continues to Lead the Diagnostic Biomarkers market.

North America will account for over 34% of global revenue in 2020. This is the largest revenue share. This can be attributed to rising disease burdens and consumer awareness, proactive government efforts, technological advances and improvements in healthcare infrastructure. In 2020, for example, the Canadian government will finance a research project worth USD 78,000 on COVID-19 biomarkers. The study’s goal was to identify biomarkers that could be used to detect COVID-19 severances.

Key players:

The key players in the Diagnostic Biomarkers Market are BIOMERIEUX, Biocrates Life Sciences Ag, Augurex Life Sciences Corp., Biomedical Corp., ILLUMINA, Ortho Clinical Diagnostics, Myriad Genetics, Target Discovery, Banyan Biomarkers, Inc., Astute Medical, Inc., Axela Inc.

Regional Analysis

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • Italy
    • France
    • UK
    • Spain
    • Poland
    • Russia
    • The Netherlands
    • Norway
    • Czech Republic
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Indonesia
    • Malaysia
    • Thailand
    • Singapore
    • Australia & New Zealand
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • The Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Northern Africa
    • Rest of MEA

Table of Contents

  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by MarkWide Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Diagnostic Biomarkers Market – Segment Analysis
    1. Overview
    2. Global Diagnostic Biomarkers Market, 2016 – 2028 (USD Million)
    3. Global Diagnostic Biomarkers Market – by Disease
      1. By Cancer
      2. By Cardiovascular Diseases
      3. By Neurological Diseases
      4. By Immunological Diseases
      5. By Others
    4. Global Diagnostic Biomarkers Market – by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    5. Market comparative analysis
  4. North America Diagnostic Biomarkers Market – Segment Analysis
    1. Overview
    2. North America Diagnostic Biomarkers Market, 2016 – 2028 (USD Million)
    3. North America Diagnostic Biomarkers Market, by Disease
      1. By Cancer
      2. By Cardiovascular Diseases
      3. By Neurological Diseases
      4. By Immunological Diseases
      5. By Others
    4. North America Diagnostic Biomarkers Market, by Country
      1. U.S.
        • U.S. Diagnostic Biomarkers Market, By Disease
          • By Cancer
          • By Cardiovascular Diseases
          • By Neurological Diseases
          • By Immunological Diseases
          • By Others
      2. Canada
        • Canada Diagnostic Biomarkers Market, By Disease
          • By Cancer
          • By Cardiovascular Diseases
          • By Neurological Diseases
          • By Immunological Diseases
          • By Others
      3. Mexico
        • Mexico Diagnostic Biomarkers Market, By Disease
          • By Cancer
          • By Cardiovascular Diseases
          • By Neurological Diseases
          • By Immunological Diseases
          • By Others
  5. Europe Diagnostic Biomarkers Market – Segment Analysis
    1. Overview
    2. Europe Diagnostic Biomarkers Market, 2016 – 2028 (USD Million)
    3. Europe Diagnostic Biomarkers Market, by Disease
      1. By Cancer
      2. By Cardiovascular Diseases
      3. By Neurological Diseases
      4. By Immunological Diseases
      5. By Others
    4. Europe Diagnostic Biomarkers Market, by Country
      1. Germany
        • Germany Diagnostic Biomarkers Market, By Disease
          • By Cancer
          • By Cardiovascular Diseases
          • By Neurological Diseases
          • By Immunological Diseases
          • By Others
      2. UK
        • UK Market, By Disease
          • By Cancer
          • By Cardiovascular Diseases
          • By Neurological Diseases
          • By Immunological Diseases
          • By Others
      3. France
        • France Diagnostic Biomarkers Market, By Disease
          • By Cancer
          • By Cardiovascular Diseases
          • By Neurological Diseases
          • By Immunological Diseases
          • By Others
      4. Spain
        • Spain Diagnostic Biomarkers Market, By Disease
          • By Cancer
          • By Cardiovascular Diseases
          • By Neurological Diseases
          • By Immunological Diseases
          • By Others
      5. Italy
        • Italy Diagnostic Biomarkers Market, By Disease
          • By Cancer
          • By Cardiovascular Diseases
          • By Neurological Diseases
          • By Immunological Diseases
          • By Others
      6. BENELUX
        • BENELUX Diagnostic Biomarkers Market, By Disease
          • By Cancer
          • By Cardiovascular Diseases
          • By Neurological Diseases
          • By Immunological Diseases
          • By Others
      7. Rest of Europe
        • Rest Of Europe Diagnostic Biomarkers Market, By Disease
          • By Cancer
          • By Cardiovascular Diseases
          • By Neurological Diseases
          • By Immunological Diseases
          • By Others
  6. Asia Pacific Diagnostic Biomarkers Market – Segment Analysis
    1. Overview
    2. Asia Pacific Diagnostic Biomarkers Market, 2016 – 2028 (USD Million)
    3. Asia Pacific Diagnostic Biomarkers Market, by Disease
      1. By Cancer
      2. By Cardiovascular Diseases
      3. By Neurological Diseases
      4. By Immunological Diseases
      5. By Others
    4. Asia Pacific Diagnostic Biomarkers Market, by Country
      1. China
        • China Diagnostic Biomarkers Market, By Disease
          • By Cancer
          • By Cardiovascular Diseases
          • By Neurological Diseases
          • By Immunological Diseases
          • By Others
      2. Japan
        • Japan Diagnostic Biomarkers Market, By Disease
          • By Cancer
          • By Cardiovascular Diseases
          • By Neurological Diseases
          • By Immunological Diseases
          • By Others
      3. India
        • India Diagnostic Biomarkers Market, By Disease
          • By Cancer
          • By Cardiovascular Diseases
          • By Neurological Diseases
          • By Immunological Diseases
          • By Others
      4. South Korea
        • South Korea Diagnostic Biomarkers Market, By Disease
          • By Cancer
          • By Cardiovascular Diseases
          • By Neurological Diseases
          • By Immunological Diseases
          • By Others
      5. South East Asia
        • South East Asia Diagnostic Biomarkers Market, By Disease
          • By Cancer
          • By Cardiovascular Diseases
          • By Neurological Diseases
          • By Immunological Diseases
          • By Others
      6. Rest of Asia Pacific
        • Rest of Asia Pacific Diagnostic Biomarkers Market, By Disease
          • By Cancer
          • By Cardiovascular Diseases
          • By Neurological Diseases
          • By Immunological Diseases
          • By Others
  7. Latin America Diagnostic Biomarkers Market – Segment Analysis
    1. Overview
    2. Latin America Diagnostic Biomarkers Market, 2016 – 2028 (USD Million)
    3. Latin America Diagnostic Biomarkers Market, by Disease
      1. By Cancer
      2. By Cardiovascular Diseases
      3. By Neurological Diseases
      4. By Immunological Diseases
      5. By Others
    4. Latin America Diagnostic Biomarkers Market, by Country
      1. Brazil
        • Brazil Diagnostic Biomarkers Market, By Disease
          • By Cancer
          • By Cardiovascular Diseases
          • By Neurological Diseases
          • By Immunological Diseases
          • By Others
      2. Argentina
        • Argentina Diagnostic Biomarkers Market, By Disease
          • By Cancer
          • By Cardiovascular Diseases
          • By Neurological Diseases
          • By Immunological Diseases
          • By Others
      3. Rest of Latin America
        • Rest of Latin America Diagnostic Biomarkers Market, By Disease
          • By Cancer
          • By Cardiovascular Diseases
          • By Neurological Diseases
          • By Immunological Diseases
          • By Others
  8. Middle East & Africa Diagnostic Biomarkers Market – Segment Analysis
    1. Overview
    2. Middle East & Africa Diagnostic Biomarkers Market, 2016 – 2028 (USD Million)
    3. Middle East & Africa Diagnostic Biomarkers Market, by Disease
      1. By Cancer
      2. By Cardiovascular Diseases
      3. By Neurological Diseases
      4. By Immunological Diseases
      5. By Others
    4. Middle East & Africa Diagnostic Biomarkers Market, by Country
      1. GCC Countries
        • GCC Countries Diagnostic Biomarkers Market, By Disease
          • By Cancer
          • By Cardiovascular Diseases
          • By Neurological Diseases
          • By Immunological Diseases
          • By Others
      2. South Africa
        • South Africa Diagnostic Biomarkers Market, By Disease
          • By Cancer
          • By Cardiovascular Diseases
          • By Neurological Diseases
          • By Immunological Diseases
          • By Others
      3. Rest of Middle East & Africa
        • Rest of Middle East & Africa Diagnostic Biomarkers Market, By Disease
          • By Cancer
          • By Cardiovascular Diseases
          • By Neurological Diseases
          • By Immunological Diseases
          • By Others
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter’s Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix – 2021
    2. Company Market Share Analysis – 2021
    3. Key Company Activities, 2018 – 2021
    4. Strategic Developments – Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Biocrates Life Sciences AG
    2. Augurex Life Sciences Corp.
    3. Biomedical Corp.
    4. Target Discovery
    5. Banyan Biomarkers Inc.
    6. Astute Medical Inc.
    7. Axela Inc.
  14. Key Primary Respondents – VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations

Segmentation

BY TYPES

  • Biomarker of Exposure
  • Biomarker of Diseases

BY APPLICATIONS

  • Risk Assessment
  • Development of Molecular Diagnostic
  • Disease Diagnosis
  • Drug Discovery and Development
  • Drug Formulation
  • Forensic Application
  • Others (DNA Fingerprinting and Others)

BY SERVICES

  • Sample Preparation
  • Assay Development
  • Biomarker Validation and Testing
  • Other Services

Major Companies

  • BIOMERIEUX
  • Biocrates Life Sciences Ag
  • Augurex Life Sciences Corp.
  • Biomedical Corp.
  • ILLUMINA
  • Ortho Clinical Diagnostics
  • Myriad Genetics
  • Target Discovery
  • Banyan Biomarkers Inc.
  • Astute Medical Inc.
  • Axela Inc.
  • Others

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF